Feed Preview

miRNAs in Cardiovascular Biology

miRNAs in Cardiovascular Biology diagram by #N/A

MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression through inhibition of protein translation or by degradation of specific transcripts. miRNAs can regulate cardiovascular health, and be potential biomarkers or targets in cardiovascular disease. Discover the latest research on miRNAs in Cardiovascular Biology here.

Top 20 most recent papers

Resolvin D-series regulates Phospholipase D both during inflammation and resolution by modulating phagocyte functions

bioRxivNovember 2, 2019
Ramya GanesanJulian G Cambronero
Frontiers in Cell and Developmental Biology

Long Non-coding RNA H19 Suppression Protects the Endothelium Against Hyperglycemic-Induced Inflammation via Inhibiting Expression of miR-29b Target Gene Vascular Endothelial Growth Factor a Through Activation of the Protein Kinase B/Endothelial Nitric Oxide Synthase Pathway

Frontiers in Cell and Developmental BiologyNovember 1, 2019
Xiao-Wen ChengHua-Qing Zhu
Circulation Research

miRNA-Mediated Suppression of a Cardioprotective Cardiokine as a Novel Mechanism Exacerbating Post-MI Remodeling by Sleep Breathing Disorders

Circulation ResearchNovember 7, 2019
Yun-Hui DUXin-Liang L Ma
Journal of Cellular Physiology

Cardioprotective effects of high-intensity interval training are mediated through microRNA regulation of mitochondrial and oxidative stress pathways

Journal of Cellular PhysiologyDecember 10, 2019
Nevena S JeremicSuresh C Tyagi

The relationship of MicroRNA-21 and plaque stability in acute coronary syndrome

MedicineNovember 1, 2019
Wangwei HeQiang Xie
International Journal of Molecular Sciences

MicroRNAs as Potential Biomarkers in Atherosclerosis

International Journal of Molecular SciencesNovember 7, 2019
Alexey V ChurovAlexander Nikolaevich Orekhov
Naunyn-Schmiedeberg's Archives of Pharmacology

MiR-137-3p exacerbates the ischemia-reperfusion injured cardiomyocyte apoptosis by targeting KLF15

Naunyn-Schmiedeberg's Archives of PharmacologyDecember 10, 2019
Ting-Ting ZhaoYong-hua Gao
Journal of Physiology and Biochemistry

MicroRNAs as the actors in the atherosclerosis scenario

Journal of Physiology and BiochemistryDecember 5, 2019
Fatemeh HajibabaieLaleh Shariati

MicroRNA biomarkers associated with type 1 myocardial infarction in HIV-positive individuals

AIDSNovember 26, 2019
Neal YuanPriscilla Ying Hsue
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

MiR-149 Aggravates Pyroptosis in Myocardial Ischemia-Reperfusion Damage via Silencing FoxO3

Medical Science Monitor : International Medical Journal of Experimental and Clinical ResearchNovember 19, 2019
Jie LinHai-Ying Li
Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie

Downregulation of TSPO expression inhibits oxidative stress and maintains mitochondrial homeostasis in cardiomyocytes subjected to anoxia/reoxygenation injury

Biomedicine & Pharmacotherapy = Biomédecine & PharmacothérapieNovember 7, 2019
Yan MengZhang-Ping Liao
Cardiovascular Research

STAT3-miR-17/20 Signaling Axis Plays a Critical Role in Attenuating Myocardial Infarction following Rapamycin Treatment in Diabetic mice

Cardiovascular ResearchNovember 18, 2019
Arun SamiduraiAnindita Das
Cardiovascular Research

Systematic Review of MicroRNA Biomarkers in Acute Coronary Syndrome and Stable Coronary Artery Disease

Cardiovascular ResearchNovember 29, 2019
Amanpreet P KaurLouise Pilote
Frontiers in Physiology

Mechanisms Responsible for Genetic Hypertension in Schlager BPH/2 Mice

Frontiers in PhysiologyOctober 18, 2019
Kristy L JacksonFrancine Z Marques
Metabolism: Clinical and Experimental

Hepatic exosome-derived miR-130a-3p attenuates glucose intolerance via suppressing PHLPP2 gene in adipocyte

Metabolism: Clinical and ExperimentalNovember 10, 2019
Jiahan WuQian-Yun Xi
Molecular Therapy. Nucleic Acids

Characterization of Circular RNAs in Vascular Smooth Muscle Cells with Vascular Calcification

Molecular Therapy. Nucleic AcidsNovember 14, 2019
Ju Hee RyuYoung-Kook Kim
Frontiers in Molecular Neuroscience

Extracellular RNA in Central Nervous System Pathologies

Frontiers in Molecular NeuroscienceOctober 17, 2019
Katharina TielkingRan Xu
Chemical Research in Toxicology

Isoprene-derived Secondary Organic Aerosol Induces the Expression of micro RNAs (miRNAs) Associated with Inflammatory/Oxidative Stress Response in Lung Cells

Chemical Research in ToxicologyNovember 25, 2019
Lauren A EavesRebecca C Fry
Cardiovascular Diabetology

Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease

Cardiovascular DiabetologyNovember 16, 2019
Ying H ShenWei Sheng Shen
American Journal of Physiology. Renal Physiology

Evaluation of the association between circulating microRNAs and kidney function in coronary angiography patients

American Journal of Physiology. Renal PhysiologyDecember 9, 2019
Axel MuendleinHeinz Drexel

See more papers from this feed

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

© 2019 Meta ULC. All rights reserved